BCKDK modification enhances the anticancer efficacy of CAR-T cells by reprogramming branched chain amino acid metabolism

This publication has 48 references indexed in Scilit:

• Metabolic programming and immune suppression in the tumor microenvironment
  Cancer Cell, 2023
• A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
  Cell Metabolism, 2022
• Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1
  European Journal of Medicinal Chemistry, 2021
• BCKDK regulates the TCA cycle through PDC in the absence of PDK family during embryonic development
  Developmental Cell, 2021
• All systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy
  Current Opinion in Biotechnology, 2020
• Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis
  Apoptosis, 2020
• Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer
  Cancer Cell, 2020
• Loss of BCAA Catabolism during Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression
  Cell Metabolism, 2019
• Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia
  Journal of Cachexia, Sarcopenia and Muscle, 2017
• Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
  EBioMedicine, 2016